JPRN-UMIN000010811已完成未知
Acute Effect of Inhaled Budesonide/Formoterol Combination Compared with Terbutaline on Airway Inflammation in Patients with Asthma - Acute Effect of Inhaled Budesonide/Formoterol on Airway Inflammation in Asthma
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 120
研究概览
简要总结
The significant correlations between eosinophils and eNO and between neutrophils and IL-8 were observed at baseline. Six hours after dosing, total eosinophil counts, IL-8 and matrix metalloproteinase-9 were significantly decreased in the group of higher dose of budesonide/formoterol(vs. those with turbutaline group, P < 0.05). The increase in FEV1 in the group of higher dose of budesonide/formoterol was significantly higher comparing to other groups 3 3 hours after dosing. In the following 24 weeks, significant asthma control was achieved in terms of eNO, FEV1, and ACQ-5 4 weeks after treatment, and the improvement was sustained to the end of study.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Patients take the following medications within 3 months prior to the study enrollment: •oral or inhaled glucocorticosteroid; •anti-inflammatory treatment; 2.Patients are hypersensitive to budesonide, formoterol, terbutaline or inhaled lactose; 3.Documented evidence of any respiratory infection within 4 weeks prior to enrolment; 4.Females who are lactating or pregnant; 5.Documented evidence of malignancy; 6.Participation in any other clinical trial or using any other investigational drug within 30 days of entry to this protocol; 7.Documented evidence of significant renal function impairment, severe cardiac disease, e.g. angina pectoris, myocardial infarction, cardiac arrhythmia, congestive heart failure (New York Heart Association Functional Classification III and IV), or any finding through physical examination or medical history giving reasonable suspicion of a disease or condition that might render the subject at high risk from treatment.
研究者
相似试验
终止
不适用
Correlation of FeNO, Blood Eosinophils, Bronchoalveolar Lavage Findings and Bronchial Epithelium Histopathology in Patients With Chronic Obstructive Pulmonary Disease and AsthmaObstructive Lung DiseasesNCT03845257Heidelberg University14
已完成
不适用
The Correlations of FeNO, Blood Eosinophils and Lung Function in Well-controlled AsthmaAsthmaNCT04454385Hat Yai Medical Education Center84
Unknown
4 期
Exhaled NO Based Treatment of Chronic Obstructive Pulmonary Disease (COPD), ICS/LABA Versus LAMACOPDNCT02546349Taipei Veterans General Hospital, Taiwan143
已完成
不适用
Steroids inhalation therapy in chronic eosinophilic pneumoniaEosinophilic pneumoniaJPRN-UMIN000030830Murayama Pediatrics1
已完成
2 期
Budesonide / Formoterol in Treatment of Exacerbations of COPDChronic Obstructive Pulmonary DiseaseNCT00239278AstraZeneca120